ZSCAN18
Zinc finger and SCAN domain-containing protein 18
Also known as: FLJ12895, ZNF447, ZSC18_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBC5
- Gene
- ZSCAN18
- Ensembl
- ENSG00000121413
- Chromosome
- 19
- Canonical length
- 510 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Primary cilium,Basal body,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
510 residues, UniProt reviewed canonical sequence.
>Q8TBC5|ZSCAN18
1 MLPLEKAFAS PRSSPAPPDL PTPGSAAGVQ QEEPETIPER TPADLEFSRL RFREFVYQEA
61 AGPHQTLARL HELCRQWLMP EARSKEQMLE LLVLEQFLGI LPDKVRPWVV AQYPESCKKA
121 ASLVEGLADV LEEPGMLLGS PAGSSSILSD GVYERHMDPL LLPGELASPS QALGAGEIPA
181 PSETPWLSPD PLFLEQRRVR EAKTEEDGPA NTEQKLKSFP EDPQHLGEWG HLDPAEENLK
241 SYRKLLLWGY QLSQPDAASR LDTEELRLVE RDPQGSSLPE GGRRQESAGC ACEEAAPAGV
301 LPELPTEAPP GDALADPPSG TTEEEEEQPG KAPDPQDPQD AESDSATGSQ RQSVIQQPAP
361 DRGTAKLGTK RPHPEDGDGQ SLEGVSSSGD SAGLEAGQGP GADEPGLSRG KPYACGECGE
421 AFAWLSHLME HHSSHGGRKR YACQGCWKTF HFSLALAEHQ KTHEKEKSYA LGGARGPQPS
481 TREAQAGARA GGPPESVEGE APPAPPEAQRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZSCAN18 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 96 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 96 nTPM
- hypothalamus: 93 nTPM
- cerebral cortex: 91 nTPM
- pituitary gland: 83 nTPM
- cerebellum: 78 nTPM
- hippocampal formation: 78 nTPM
Single-cell type
- late spermatids: 113 nCPM
- ovarian stromal cells: 98 nCPM
- fallopian tube ciliated cells: 97 nCPM
- syncytiotrophoblasts: 94 nCPM
- ependymal cells: 91 nCPM
- respiratory ciliated cells: 83 nCPM
Immune cell
- naive B-cell: 1.5 nTPM
- eosinophil: 1.4 nTPM
- neutrophil: 1.4 nTPM
- basophil: 1 nTPM
- MAIT T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.9 nTPM
Brain region
- hypothalamus: 130 nTPM
- cerebral cortex: 118 nTPM
- basal ganglia: 118 nTPM
- medulla oblongata: 115 nTPM
- midbrain: 113 nTPM
- pons: 110 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZSCAN18 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZSCAN18 as an antibody target. Whether an autoantibody or antibody against ZSCAN18 could matter depends on whether native ZSCAN18 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZSCAN18 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZSCAN18 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...